Ultrasonic-assisted degradation of phenazopyridine with a combination of Sm-doped ZnO nanoparticles and inorganic oxidants

Pure and samarium doped ZnO nanoparticles were synthesized by a sonochemical method and characterized by TEM, SEM, EDX, XRD, Pl, and DRS techniques. The average crystallite size of pure and Sm-doped ZnO nanoparticles was about 20 nm. The sonocatalytic activity of pure and Sm-doped ZnO nanoparticles was considered toward degradation of phenazopyridine as a model organic contaminant. The Sm-doped ZnO nanoparticles with Sm concentration of 0.4 mol% indicated a higher sonocatalytic activity (59%) than the pure ZnO (51%) and other Sm-doped ZnO nanoparticles. It was believed that Sm³⁺ ion with optimal concentration (0.4 mol%) can act as superficial trapping for electrons in the conduction band of ZnO and delayed the recombination of charge carriers. The influence of the nature and concentration of various oxidants, including periodate, hydrogen peroxide, peroxymonosulfate, and peroxydisulfate on the sonocatalytic activity of Sm-doped ZnO nanoparticles was studied. The influence of the oxidants concentration (0.2–1.4 g L⁻¹) on the degradation rate was established by the 3D response surface and the 2D contour plots. The results demonstrated that the utilizing of oxidants in combination with Sm-doped ZnO resulting in rapid removal of contaminant, which can be referable to a dual role of oxidants; (i) scavenging the generated electrons in the conduction band of ZnO and (ii) creating highly reactive radical species under ultrasonic irradiation. It was found that the Sm-doped ZnO and periodate combination is the most efficient catalytic system under ultrasonic irradiation.     

Highly Selective Potentiometric Sensor for Determining Phenazopyridine Hydrochloride in Biological Fluids Using N,N′-(Pyromellitoyl)-bis-L-tyrosine Dimethyl Ester

A new membrane selective electrode based on the potentiometric method was developed for the determination of phenazopyridine. The membrane signal is based on the interaction of N,N′-(pyromellitoyl)-bis-L-tyrosine dimethyl ester with phenazopyridine. The sensor displays a linear response with a slope of 61.1 mV decade^?1 for phenazopyridine concentrations in the range of 1.0 × 10^?2–1.0 × 10^?5 mol L^?1 and with detection limit of 8.0 × 10^?6 mol L^?1 of phenazopyridine. The electrode enjoys a fast response time. Application of this potentiometric sensor for phenazopyridine determination in pharmaceuticals, urine, and blood serum samples is reported without any special pretreatment required.     

Hollow fiber-based liquid-liquid-liquid microextraction followed by flow injection analysis using column-less HPLC for the determination of phenazopyridine in plasma and urine

Hollow fiber-based liquid-liquid-liquid microextraction (HF-LLLME) followed by flow injection analysis and diode array detection (FIA-DAD) was applied as a simple and sensitive quantitative method for the determination of phenazopyridine in urine and plasma samples. Flow injection system included a conventional HPLC system (without a chromatographic column) and a diode array detector. The extraction of phenazopyridine was carried out using diphenyl ether as the organic phase for filling the pores of the hollow fiber wall, and 0.1 M H(2)SO(4) solution as acceptor phase in the lumen of the fiber. The factors affecting the HF-LLLME and flow injection analysis including type of organic solvent, pH of donor phase, extraction temperature, extraction time, stirring rate, and pH of mobile phase were investigated and the optimal extraction conditions were established. With the consumption of 5 mL of sample solution, the enrichment factor was about 230. The limit of detection was 0.5 μg/L with inter- and intra-day precision being (RSD%) 6.9 and 4.9, respectively. Excellent linearity was found between 5 and 200 μg/L.     

光谱法研究盐酸非那吡啶与牛血清白蛋白的结合作用

运用光谱学方法研究了在生理pH值条件下盐酸非那吡啶(PHE)与牛血清白蛋白之间的结合作用。通过荧光光谱和紫外吸收光谱确定了盐酸非那吡啶对牛血清白蛋白的荧光猝灭机理。依据Scatchard方程测定了不同温度下该结合反应的结合常数和结合位点数。根据热力学方程讨论了两者间的主要作用力类型。结合同步荧光光谱分析了盐酸非那吡啶对牛血清白蛋白构象的影响。盐酸非那吡啶对牛血清白蛋白的荧光猝灭机制主要为静态猝灭和非辐射能量转移。在15, 25, 37℃时盐酸非那吡啶与牛血清白蛋白的结合常数K_b分别为2.47×107, 9.15×106, 4.36×106 L·mol-1,它们之间平均结合位点数n为1。结合反应的热力学参数为ΔH=-71.2 kJ·mol-1,ΔS=124.8 J·mol-1·K-1。热力学函数计算结果表明,该作用过程是一个熵增加,Gibbs自由能降低的自发分子间作用过程。依据Frster能量转移理论确定PHE与BSA间的结合距离为1.61 nm。两者结合的主要作用力类型是静电作用力。盐酸非那吡啶在体内能够被血清蛋白存储和转运,但结合时对蛋白构象有一定影响。     

Determination of phenazopyridine in human plasma via LC–MS and subsequent development of a pharmacokinetic model

This paper describes a new LC–MS method for the determination of phenazopyridine and the subsequent development of a pharmacokinetic model for phenazopyridine in vivo. Phenazopyridine hydrochloride is a strong analgesic used in the treatment of urinary tract infections. Although it has been used as a clinical treatment for a very long time, pharmacokinetic data and suitable methods for its determination in plasma are currently lacking. The study described in this paper used high performance liquid chromatography–mass spectrometry, HPLC–MS, to determine the plasma concentrations of phenazopyridine in human subjects after oral administration. After liquid–liquid extraction, the phenazopyridine in the plasma was analyzed on a C₁₈ column under SIM mode. A double-peak phenomenon was observed in most of the concentration–time profiles of the subjects. Although some drugs are known to cause this phenomenon, phenazopyridine has not been reported to do so. Several possible causes were analyzed in order to obtain an explanation. We proposed a two-site absorption compartment model to fit the concentration data in vivo, which has one more absorption site than the classical one-compartment model. The model describes the concentration profiles in different dose groups well and could provide an explanation for the double-peak phenomenon. The three dose groups exhibited similar model parameters and a linear pharmacokinetic process over the dose range used.     

Simultaneuus Spectrophotometric Deermination of Phenazo-Pyridine and Nitrofurantoin in Tablets

Abstract

Two spectrophotometric methods are proposed for the simultaneous spectrophotometric determination of phenaaopyridine and nitrofurantoin in tablets. No preliminary separation step is required. The first method involves the use of the modified Vierardt equation as developed by Glenn. The second method is based on the spectral changes induced bg reduction using Zn/HCl; the absorption spectrum of nitrofurantoin completely disappears, Phenazopyridine on the other hand develops a new absorption spectra at 320 nm, the absorbance ratio of the peak at 380 nm to that at 320 nm could be adopted to develop a spectrophotometric method for the determination of both compounds in admixture. The suggested methods were applied to the determination of the two compounds in tablets, and the results obtained were accurate and precise.     

质子化非那吡啶在功能化复合介孔膜修饰的液/液界面上的转移反应

采用循环伏安法和差分脉冲伏安法考察了临床药物盐酸非那吡啶在功能化复合介孔膜修饰的水/1,6-二氯己烷(W/DCH)界面上的转移行为. 研究结果表明, 盐酸非那吡啶中的非那吡啶(PAP) 可在酸性条件下发生质子化形成非那吡啶阳离子(HPAP⁺)并在该界面上发生转移. 根据循环伏安曲线峰电流与扫描速率的关系以及Randles-Sev$\check{c}$ik 方程, 计算得到HPAP⁺在复合介孔膜内水相中的扩散系数为5.14×10^-8 cm²/s. 研究发现, 相对于空白膜修饰的W/DCH界面, 该复合介孔膜修饰的W/DCH界面可增强非那吡啶阳离子转移时的电流响应, 并提升非那吡啶阳离子的检测性能. 另外, 利用液/液界面电化学方法绘制了非那吡啶在功能化复合介孔膜修饰的W/DCH界面上的离子分布图, 从而得到非那吡啶在该界面上不同条件下的分布情况及其分配系数和吉布斯转移自由能.     

Selective pretreatment and determination of phenazopyridine using an imprinted polymer-electrospray ionization ion mobility spectrometry system

In this research, selective separation and determination of phenazopyridine (PAP) is demonstrated using molecular imprinted polymer (MIP) coupled with electrospray ionization ion mobility spectrometry (ESI-IMS). In the non-covalent approach, selective MIP produced using PAP and methacrylic acid (MAA) as a template molecule and monomer, respectively. The created polymer is utilized as a media for solid-phase extraction (SPE), revealing selective binding properties for the analyte from pharmaceutical and serum samples. A coupled MIP-IMS makes it possible to quantitize PAP in the range of 1-100 ng mL⁻¹ and with a 0.2 ng mL⁻¹ detection limit. Furthermore, the MIP selectivity is evaluated by application of some substances with analogous and different molecular structures to that of PAP. This method is successfully applied for the determination of PAP in pharmaceutical and serum samples.     

Determination of phenazopyridine in human plasma by high performance liquid chromatography

Summary A simple, low-cost, sensitive and selective HPLC method was developed for the determination of phenazopyridine in human plasma. The method employs UV detection of phenazopyridine and of the internal Standard at 2 different wavelengths. Calibration curves were linear over a large dynamic range, i.e., within 0.05–10.0 μg mL⁻¹ with limit of quantification of 0.05 μg mL⁻¹, and a limit of detection of 0.01 μg mL⁻¹.     

Simultaneous high-performance liquid chromatographic determination of phenazopyridine and nitrofurantoin in tablets

Summary A reversed-phase, High-performance Liquid chromatographic method for the simultaneous determination of phenazopyridine and nitrofurantoin in tablets is described. An aminopropyl-silica (APS-Hypensil) 5μm column and a mobile phase consisting of Methanol:H₂O: 0.05M sodium dihydrogen phosphate (50∶45∶5) were used. Calibration curves were linear over the concentration range 2–20μg/ml, with minimum detectability of 10ng/ml for both drugs. The method was applied to tablets containing the two species and the results obtained were compared to those given with a published method.